Journal Summary - Discover more summaries and articles from M3 India

Journal Summaries

Oncology

Dermatologic Oncology

CD133 is associated with increased melanoma cell survival after multikinase inhibition

Journal of Oncology | Jul 21, 2019 Dermatologic Oncology

Safety and efficacy of immune checkpoint inhibitor therapy in patients with HIV infection and advanced-stage cancer: A systematic review

JAMA | Jul 17, 2019 Dermatologic Oncology

Intraoral confocal microscopy of suspicious oral lesions: A prospective case series

International Journal of Dermatology | Jul 17, 2019 Dermatologic Oncology

The impact of targeted therapies and immunotherapy in melanoma brain metastases: A systematic review and meta-analysis

Cancer | Jul 16, 2019 Dermatologic Oncology

2-cm vs 4-cm surgical excision margins for primary cutaneous melanoma thicker than 2 mm: Long-term follow-up of a multicentre, randomised trial

The Lancet | Jul 11, 2019 Dermatologic Oncology

Genome-wide association studies and polygenic risk scores for skin cancer: Clinically useful yet?

British Journal of Dermatology | Jul 11, 2019 Dermatologic Oncology

IPH4102, a first-in-class anti-KIR3DL2 monoclonal antibody, in patients with relapsed or refractory cutaneous T-cell lymphoma: An international, first-in-human, open-label, phase 1 trial

The Lancet Oncology | Jul 03, 2019 Dermatologic Oncology

Treatment and survival of Merkel cell carcinoma since 1993: A population-based cohort study in The Netherlands

Journal of the American Academy of Dermatology | Jul 03, 2019 Dermatologic Oncology

Comparison of survival between patients with single vs multiple primary cutaneous melanomas

JAMA Dermatology | Jul 02, 2019 Dermatologic Oncology

Development and initial validation of calculated tumor area as a prognostic tool in cutaneous malignant melanoma

JAMA Dermatology | Jul 01, 2019 Dermatologic Oncology

« Prev 1 … 26 27 28 29 30 … 57 Next »

CD133 is associated with increased melanoma cell survival after multikinase inhibition

Safety and efficacy of immune checkpoint inhibitor therapy in patients with HIV infection and advanced-stage cancer: A systematic review

Intraoral confocal microscopy of suspicious oral lesions: A prospective case series

The impact of targeted therapies and immunotherapy in melanoma brain metastases: A systematic review and meta-analysis

2-cm vs 4-cm surgical excision margins for primary cutaneous melanoma thicker than 2 mm: Long-term follow-up of a multicentre, randomised trial

Genome-wide association studies and polygenic risk scores for skin cancer: Clinically useful yet?

IPH4102, a first-in-class anti-KIR3DL2 monoclonal antibody, in patients with relapsed or refractory cutaneous T-cell lymphoma: An international, first-in-human, open-label, phase 1 trial

Treatment and survival of Merkel cell carcinoma since 1993: A population-based cohort study in The Netherlands

Comparison of survival between patients with single vs multiple primary cutaneous melanomas

Development and initial validation of calculated tumor area as a prognostic tool in cutaneous malignant melanoma

BRI or BMI: What is More Efficient?

Enhancing Conventional Diabetes Management with Lifestyle and Nutritional Interventions

These Popular Snacks Linked a Decline in Mental Health

Awareness for COPD: MCQ challenge

Addressing Sleep Disorders with Integrative Solutions: From Pharmaceuticals to Natural Remedies

CD133 is associated with increased melanoma cell survival after multikinase inhibition

Safety and efficacy of immune checkpoint inhibitor therapy in patients with HIV infection and advanced-stage cancer: A systematic review

Intraoral confocal microscopy of suspicious oral lesions: A prospective case series

The impact of targeted therapies and immunotherapy in melanoma brain metastases: A systematic review and meta-analysis

2-cm vs 4-cm surgical excision margins for primary cutaneous melanoma thicker than 2 mm: Long-term follow-up of a multicentre, randomised trial

Genome-wide association studies and polygenic risk scores for skin cancer: Clinically useful yet?

IPH4102, a first-in-class anti-KIR3DL2 monoclonal antibody, in patients with relapsed or refractory cutaneous T-cell lymphoma: An international, first-in-human, open-label, phase 1 trial

Treatment and survival of Merkel cell carcinoma since 1993: A population-based cohort study in The Netherlands

Comparison of survival between patients with single vs multiple primary cutaneous melanomas

Development and initial validation of calculated tumor area as a prognostic tool in cutaneous malignant melanoma

BRI or BMI: What is More Efficient?

Enhancing Conventional Diabetes Management with Lifestyle and Nutritional Interventions

These Popular Snacks Linked a Decline in Mental Health

Awareness for COPD: MCQ challenge

Addressing Sleep Disorders with Integrative Solutions: From Pharmaceuticals to Natural Remedies

Select Specialty

Select Topic